Treating Opioid Use Disorders

Marlene Kurban • August 2, 2021

Medications, including buprenorphine (Suboxone ® , Subutex ® ), methadone, and extended release naltrexone (Vivitrol ® ), are effective for the treatment of opioid use disorders. Medications should be combined with behavioral counseling for a “whole patient” approach, known as Medication Assisted Treatment (MAT).

MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates. The prescribed medication operates to normalize brain chemistry, block the euphoric effects of alcohol and opioids, relieve physiological cravings, and normalize body functions without the negative and euphoric effects of the substance used.

This treatment approach has been shown to:

  • Improve patient survival
  • Increase retention in treatment
  • Decrease illicit opiate use and other criminal activity among people with substance use disorders
  • Increase patients’ ability to gain and maintain employment
  • Improve birth outcomes among women who have substance use disorders and are pregnant

Research also shows that these medications and therapies can contribute to lowering a person’s risk of contracting HIV or hepatitis C by reducing the potential for relapse. 

The post Treating Opioid Use Disorders appeared first on InterCommunity.

May 29, 2025
InterCommunity First to Offer Inpatient Cocaine Withdrawal Management in  Greater Hartford
May 27, 2025
Big Improvements Happening at InterCommunity! 
May 21, 2025
Health, Hope & Healing, One Step at a Time Reflecting on Mental Health Awareness Month at InterCommunity
April 25, 2025
Breathe Easier This Spring: Managing Allergies with InterCommunity
April 24, 2025
InterCommunity’s Journey Forward
March 4, 2025
InterCommunity Celebrates Successful Ribbon-Cutting for Expanded Health Facility
February 26, 2025
Changing the Meaning of Care
February 13, 2025
CT Community Health Centers Navigating Uncertainty, Funding Delays
January 17, 2025
InterCommunity will continue to inspire hope and promote whole-person health by providing high-quality, affordable, compassionate healthcare for everyone.
LDBI Staff
January 6, 2025
For individuals battling opioid addiction, especially those impacted by fentanyl, hope can feel out of reach. InterCommunity Inc. is changing that. As the only provider in the region offering Low-Dose Buprenorphine Induction (LDBI), InterCommunity is leading the way with a safe, more compassionate approach to recovery.
More Posts